Westlake Chemical Q3 revenue misses estimates

Reuters

2025/10/30

<a href="https://laohu8.com/S/WLK">Westlake Chemical</a> Q3 revenue misses estimates

Overview

Westlake Chemical Q3 revenue missed analyst expectations
Net income for Q3 2025 decreased compared to Q3 2024
Company renewed Ethylene Sales Agreement through 2027 at existing terms

Outlook

Company renewed Ethylene Sales Agreement through 2027 at existing terms

Result Drivers

ETHYLENE SALES AGREEMENT - Stable cash flows maintained despite declining spot ethylene prices due to Ethylene Sales Agreement
HIGHER MAINTENANCE EXPENSES - Decrease in MLP distributable cash flow due to higher maintenance capital expenditures

Key Details

Metric	Beat/Miss	Actual	Consensus Estimate
Q3 Revenue	Miss	$276.54 mln	$303 mln (1 Analyst)
Q3 EPS		$0.42
Q3 Net Income		$86.21 mln
Q3 EBITDA		$126.07 mln
Q3 Gross Profit		$99.42 mln
Q3 Income from Operations		$91.97 mln

Analyst Coverage

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the commodity chemicals peer group is "buy"
Wall Street's median 12-month price target for Westlake Chemical Partners LP is $25.50, about 25.7% above its October 29 closing price of $18.95
The stock recently traded at 10 times the next 12-month earnings vs. a P/E of 12 three months ago

Press Release: ID:nBw1cjWqWa

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2579709114"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2579709114\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2579709114?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-30 18:48","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2579709114","market":"fut","top_or_hot":-1,"title":"Westlake Chemical Q3 revenue misses estimates","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title><a href=\"https://laohu8.com/S/WLK\">Westlake Chemical</a> Q3 revenue misses estimates</title></head><body><p><span>Overview</span></p><ul><li><p>Westlake Chemical Q3 revenue missed analyst expectations</p></li><li><p>Net income for Q3 2025 decreased compared to Q3 2024</p></li><li><p>Company renewed Ethylene Sales Agreement through 2027 at existing terms</p></li></ul><p><span>Outlook</span></p><ul><li><p>Company renewed Ethylene Sales Agreement through 2027 at existing terms</p></li></ul><p><span>Result Drivers</span></p><ul><li><p>ETHYLENE SALES AGREEMENT - Stable cash flows maintained despite declining spot ethylene prices due to Ethylene Sales Agreement</p></li><li><p>HIGHER MAINTENANCE EXPENSES - Decrease in MLP distributable cash flow due to higher maintenance capital expenditures</p></li></ul><p><span>Key Details</span></p><table><tbody><tr><td><p><span>Metric</span></p></td><td><p><span>Beat/Miss</span></p></td><td><p><span>Actual</span></p></td><td><p><span>Consensus Estimate</span></p></td></tr><tr><td><p>Q3 Revenue</p></td><td><p>Miss</p></td><td><p>$276.54 mln</p></td><td><p>$303 mln (1 Analyst)</p></td></tr><tr><td><p>Q3 EPS</p></td><td></td><td><p>$0.42</p></td><td></td></tr><tr><td><p>Q3 Net Income</p></td><td></td><td><p>$86.21 mln</p></td><td></td></tr><tr><td><p>Q3 EBITDA</p></td><td></td><td><p>$126.07 mln</p></td><td></td></tr><tr><td><p>Q3 Gross Profit</p></td><td></td><td><p>$99.42 mln</p></td><td></td></tr><tr><td><p>Q3 Income from Operations</p></td><td></td><td><p>$91.97 mln</p></td><td></td></tr></tbody></table><p><span>Analyst Coverage</span></p><ul><li><p>The current average analyst rating on the shares is \"buy\" and the breakdown of recommendations is 1 \"strong buy\" or \"buy\", 1 \"hold\" and no \"sell\" or \"strong sell\"</p></li><li><p>The average consensus recommendation for the commodity chemicals peer group is \"buy\"</p></li><li><p>Wall Street's median 12-month price target for <a href=\"https://laohu8.com/S/WLKP\">Westlake Chemical Partners LP</a> is $25.50, about 25.7% above its October 29 closing price of $18.95</p></li><li><p>The stock recently traded at 10 times the next 12-month earnings vs. a P/E of 12 three months ago</p></li></ul><p>Press Release: <span>ID:nBw1cjWqWa</span></p><p>For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.</p><p>(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Westlake Chemical Q3 revenue misses estimates</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWestlake Chemical Q3 revenue misses estimates\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time smaller\">2025-10-30 18:48</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title><a href=\"https://laohu8.com/S/WLK\">Westlake Chemical</a> Q3 revenue misses estimates</title></head><body><p><span>Overview</span></p><ul><li><p>Westlake Chemical Q3 revenue missed analyst expectations</p></li><li><p>Net income for Q3 2025 decreased compared to Q3 2024</p></li><li><p>Company renewed Ethylene Sales Agreement through 2027 at existing terms</p></li></ul><p><span>Outlook</span></p><ul><li><p>Company renewed Ethylene Sales Agreement through 2027 at existing terms</p></li></ul><p><span>Result Drivers</span></p><ul><li><p>ETHYLENE SALES AGREEMENT - Stable cash flows maintained despite declining spot ethylene prices due to Ethylene Sales Agreement</p></li><li><p>HIGHER MAINTENANCE EXPENSES - Decrease in MLP distributable cash flow due to higher maintenance capital expenditures</p></li></ul><p><span>Key Details</span></p><table><tbody><tr><td><p><span>Metric</span></p></td><td><p><span>Beat/Miss</span></p></td><td><p><span>Actual</span></p></td><td><p><span>Consensus Estimate</span></p></td></tr><tr><td><p>Q3 Revenue</p></td><td><p>Miss</p></td><td><p>$276.54 mln</p></td><td><p>$303 mln (1 Analyst)</p></td></tr><tr><td><p>Q3 EPS</p></td><td></td><td><p>$0.42</p></td><td></td></tr><tr><td><p>Q3 Net Income</p></td><td></td><td><p>$86.21 mln</p></td><td></td></tr><tr><td><p>Q3 EBITDA</p></td><td></td><td><p>$126.07 mln</p></td><td></td></tr><tr><td><p>Q3 Gross Profit</p></td><td></td><td><p>$99.42 mln</p></td><td></td></tr><tr><td><p>Q3 Income from Operations</p></td><td></td><td><p>$91.97 mln</p></td><td></td></tr></tbody></table><p><span>Analyst Coverage</span></p><ul><li><p>The current average analyst rating on the shares is \"buy\" and the breakdown of recommendations is 1 \"strong buy\" or \"buy\", 1 \"hold\" and no \"sell\" or \"strong sell\"</p></li><li><p>The average consensus recommendation for the commodity chemicals peer group is \"buy\"</p></li><li><p>Wall Street's median 12-month price target for <a href=\"https://laohu8.com/S/WLKP\">Westlake Chemical Partners LP</a> is $25.50, about 25.7% above its October 29 closing price of $18.95</p></li><li><p>The stock recently traded at 10 times the next 12-month earnings vs. a P/E of 12 three months ago</p></li></ul><p>Press Release: <span>ID:nBw1cjWqWa</span></p><p>For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.</p><p>(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"WLKP","symbol_name":"Westlake Chemical Partners LP","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251030:nL1N3WB0LJ:1","article_id":"2579709114","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2579709114","pubTimestamp":1761821330,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Westlake Chemical Q3 revenue misses estimatesOverviewWestlake Chemical Q3 revenue missed analyst expectationsNet income for Q3 2025 decreased compared to Q3 2024Company renewed Ethylene Sales Agreemen","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"WLKP":"Westlake Chemical Partners LP","BK4590":"PTP","BK4090":"商品化工","WLK":"Westlake Chemical Corp"},"translate_title":"西湖化学第三季度营收未达预期","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"WLK":0.9,"WLKP":0.9},"content_text":"Westlake Chemical Q3 revenue misses estimatesOverviewWestlake Chemical Q3 revenue missed analyst expectationsNet income for Q3 2025 decreased compared to Q3 2024Company renewed Ethylene Sales Agreement through 2027 at existing termsOutlookCompany renewed Ethylene Sales Agreement through 2027 at existing termsResult DriversETHYLENE SALES AGREEMENT - Stable cash flows maintained despite declining spot ethylene prices due to Ethylene Sales AgreementHIGHER MAINTENANCE EXPENSES - Decrease in MLP distributable cash flow due to higher maintenance capital expendituresKey DetailsMetricBeat/MissActualConsensus EstimateQ3 RevenueMiss$276.54 mln$303 mln (1 Analyst)Q3 EPS$0.42Q3 Net Income$86.21 mlnQ3 EBITDA$126.07 mlnQ3 Gross Profit$99.42 mlnQ3 Income from Operations$91.97 mlnAnalyst CoverageThe current average analyst rating on the shares is \"buy\" and the breakdown of recommendations is 1 \"strong buy\" or \"buy\", 1 \"hold\" and no \"sell\" or \"strong sell\"The average consensus recommendation for the commodity chemicals peer group is \"buy\"Wall Street's median 12-month price target for Westlake Chemical Partners LP is $25.50, about 25.7% above its October 29 closing price of $18.95The stock recently traded at 10 times the next 12-month earnings vs. a P/E of 12 three months agoPress Release: ID:nBw1cjWqWaFor questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}